We report a patient who had cerebral infarction associated with heparin-induced thrombocytopenia (HIT) 
was stopped. The patient was transferred to our hospital on day 4. He had almost normal blood chemistry and cell counts, including a normal platelet count (192×10 3 /μL). Anticoagulation testing revealed slightly elevated levels of Ddimer (6.8 μg/mL [normal <1.0 μg/mL]) and FDP
. On MRA, the main trunk of the left middle cerebral artery was occluded (Fig. 1F) 
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(high probability). On the other hand, the disseminated intravascular coagulation (DIC) score was 4 points, indicating a low probability of DIC. Argatroban therapy normalized the platelet count and the D-dimer level with negative HIT-Ab (OD405=0.177), and the patient's condition improved within two weeks. Resolution of DVT seen on follow-up venous ultrasonography on day 56 also supported the effectiveness of argatroban.
Discussion
We report a patient with encephalitis and HIT, the combination of which has not been previously described. Even though encephalitis can cause cerebral infarction or inflammatory lesions with similar neurological deficits, the symptoms our patient which developed on day 23 were likely due to HIT-associated cerebral infarction for several reasons. First, HIT-Ab was positive with severe thrombosis and decreased platelets, and these findings were resolved by discontinuation of heparin and administration of argatroban. Second, the improved CSF findings and clinical recovery at the onset of cerebral infarction seemed to rule out aggravation of encephalitis. Furthermore, while inflammatoryassociated cerebral infarction often occurs in the territories of small arteries, our patient had a new lesion in the main trunk of the left middle cerebral artery, with a high intensity DWI lesion matching the vascular territory. Development of cerebral infarction 7 days before thrombocytopenia in our patient also does not rule out HIT, since recent studies demonstrated that thrombocytopenia is often absent at the onset of thromboembolic complications and, sometimes, may be absent during the entire disease course (4). We cannot exclude the possibility that the HIT-associated cerebral infarction occurred independently of the encephalitis; however, the lack of other causes of vascular damage suggests that encephalitis may trigger or predispose to HIT-associated infarction. The pathophysiological mechanism by which encephalitis causes HIT-associated cerebral infarction remains unknown. However, in encephalitis, vascular damage in cerebral arteries involves leukocyte infiltration into arterial walls (5).
These activated leukocytes release chemokines, such as CCL 17 and CCL22, which may subsequently activate platelets, thereby releasing platelet factor 4 to form a complex with HIT-Ab and heparin (6) 
